AR054126A1 - Utilizacion de un benzoilderivado del 3-aminocarbazol para la produccion de un farmaco para el tratamiento de un desorden asociado a la produccion de prostaglandina e2 (pge2) - Google Patents
Utilizacion de un benzoilderivado del 3-aminocarbazol para la produccion de un farmaco para el tratamiento de un desorden asociado a la produccion de prostaglandina e2 (pge2)Info
- Publication number
- AR054126A1 AR054126A1 ARP060101981A ARP060101981A AR054126A1 AR 054126 A1 AR054126 A1 AR 054126A1 AR P060101981 A ARP060101981 A AR P060101981A AR P060101981 A ARP060101981 A AR P060101981A AR 054126 A1 AR054126 A1 AR 054126A1
- Authority
- AR
- Argentina
- Prior art keywords
- production
- treatment
- group
- benzoilderived
- aminocarbazol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Utilizacion de un benzoilderivado del 3-aminocarbazol para la produccion de un fármaco para el tratamiento preventivo y terapéutico de un desorden elegido del grupo que comprende procesos inflamatorios, dolor, fiebre, tumores, enfermedade de Alzheimer y arterioesclerosis. Procedimiento de tratamiento preventivo o terapéutico de un desorden elegido del grupo que comprende procesos inflamatorios, dolor, fiebre, tumores, enfermedad de Alzheimer y arterioesclerosis, en el cual se administra a un sujeto una cantidad terapéuticamente eficaz de un benzoilderivado del 3-aminocarbazol de la presente. Reivindicacion 1: Utilizacion de un compuesto elegido del grupo que comprende los benzoilderivados del 3-aminocarbazol de formula (1) indicados en la siguiente tabla 1: para la produccion de un fármaco para el tratamiento preventivo de un desorden elegido del grupo que comprende procesos inflamatorios, dolor, fiebre, tumores, enfermedad de Alzheimer y arterioesclerosis.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000909A ITMI20050909A1 (it) | 2005-05-19 | 2005-05-19 | Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2- |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054126A1 true AR054126A1 (es) | 2007-06-06 |
Family
ID=35219704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060101981A AR054126A1 (es) | 2005-05-19 | 2006-05-17 | Utilizacion de un benzoilderivado del 3-aminocarbazol para la produccion de un farmaco para el tratamiento de un desorden asociado a la produccion de prostaglandina e2 (pge2) |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8686021B2 (es) |
| EP (1) | EP1881826B1 (es) |
| JP (1) | JP5086991B2 (es) |
| KR (1) | KR101312579B1 (es) |
| CN (1) | CN101166528B (es) |
| AR (1) | AR054126A1 (es) |
| AT (1) | ATE473739T1 (es) |
| AU (1) | AU2006246688B2 (es) |
| BR (1) | BRPI0609718A2 (es) |
| CA (1) | CA2604562C (es) |
| DE (1) | DE602006015457D1 (es) |
| DK (1) | DK1881826T3 (es) |
| EA (1) | EA012724B1 (es) |
| ES (1) | ES2347174T3 (es) |
| GE (1) | GEP20094738B (es) |
| HK (1) | HK1119571A1 (es) |
| IL (1) | IL186072A (es) |
| IT (1) | ITMI20050909A1 (es) |
| MX (1) | MX2007013491A (es) |
| PL (1) | PL1881826T3 (es) |
| PT (1) | PT1881826E (es) |
| SI (1) | SI1881826T1 (es) |
| UA (1) | UA94044C2 (es) |
| WO (1) | WO2006122680A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20051523A1 (it) | 2005-08-03 | 2007-02-04 | Acraf | Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo |
| EP2119705A1 (en) | 2008-05-14 | 2009-11-18 | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. | 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor |
| US8880004B2 (en) | 2009-05-14 | 2014-11-04 | Qualcomm Incorporated | System and method for resolving conflicts between air interfaces in a wireless communication system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
| US6399631B1 (en) * | 1999-07-23 | 2002-06-04 | Pfizer Inc. | Carbazole neuropeptide Y5 antagonists |
| AU6000900A (en) | 1999-07-23 | 2001-02-13 | Astrazeneca Uk Limited | Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| US6348472B1 (en) * | 1999-08-26 | 2002-02-19 | Bristol-Myers Squibb Company | NPY antagonists: spiroisoquinolinone derivatives |
| DE10125961A1 (de) * | 2001-05-29 | 2002-12-12 | Boehringer Ingelheim Int | Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden |
| CA2403307A1 (en) * | 2001-10-23 | 2003-04-23 | Neurogen Corporation | Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives |
| KR20030042344A (ko) * | 2001-11-22 | 2003-05-28 | 한국생명공학연구원 | 에레모필란계 화합물 또는 곰취추출물을 유효성분으로함유하는 염증질환 치료제, 면역질환 치료제, 및 암 치료제 |
| ES2193875B2 (es) * | 2002-04-09 | 2005-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos. |
| KR100402714B1 (ko) * | 2002-12-23 | 2003-11-13 | 한국생명공학연구원 | 디테르펜계 화합물을 염증질환, 면역질환 및 암 치료제로사용하는 신규한 용도 |
-
2005
- 2005-05-19 IT IT000909A patent/ITMI20050909A1/it unknown
-
2006
- 2006-05-03 BR BRPI0609718-9A patent/BRPI0609718A2/pt not_active IP Right Cessation
- 2006-05-03 MX MX2007013491A patent/MX2007013491A/es active IP Right Grant
- 2006-05-03 DK DK06753538.5T patent/DK1881826T3/da active
- 2006-05-03 CA CA2604562A patent/CA2604562C/en not_active Expired - Fee Related
- 2006-05-03 KR KR1020077029661A patent/KR101312579B1/ko not_active IP Right Cessation
- 2006-05-03 JP JP2008511591A patent/JP5086991B2/ja not_active Expired - Fee Related
- 2006-05-03 SI SI200630781T patent/SI1881826T1/sl unknown
- 2006-05-03 EA EA200702534A patent/EA012724B1/ru not_active IP Right Cessation
- 2006-05-03 AT AT06753538T patent/ATE473739T1/de active
- 2006-05-03 PL PL06753538T patent/PL1881826T3/pl unknown
- 2006-05-03 US US11/909,393 patent/US8686021B2/en not_active Expired - Fee Related
- 2006-05-03 ES ES06753538T patent/ES2347174T3/es active Active
- 2006-05-03 EP EP06753538A patent/EP1881826B1/en not_active Not-in-force
- 2006-05-03 UA UAA200713598A patent/UA94044C2/ru unknown
- 2006-05-03 CN CN2006800144162A patent/CN101166528B/zh not_active Expired - Fee Related
- 2006-05-03 GE GEAP200610441A patent/GEP20094738B/en unknown
- 2006-05-03 AU AU2006246688A patent/AU2006246688B2/en not_active Ceased
- 2006-05-03 WO PCT/EP2006/004348 patent/WO2006122680A1/en active Application Filing
- 2006-05-03 PT PT06753538T patent/PT1881826E/pt unknown
- 2006-05-03 DE DE602006015457T patent/DE602006015457D1/de active Active
- 2006-05-17 AR ARP060101981A patent/AR054126A1/es not_active Application Discontinuation
-
2007
- 2007-09-19 IL IL186072A patent/IL186072A/en not_active IP Right Cessation
-
2008
- 2008-10-23 HK HK08111668.0A patent/HK1119571A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL1881826T3 (pl) | 2010-12-31 |
| IL186072A (en) | 2012-05-31 |
| JP2008540591A (ja) | 2008-11-20 |
| EA012724B1 (ru) | 2009-12-30 |
| EP1881826B1 (en) | 2010-07-14 |
| US20080287518A1 (en) | 2008-11-20 |
| CN101166528A (zh) | 2008-04-23 |
| DE602006015457D1 (de) | 2010-08-26 |
| GEP20094738B (en) | 2009-07-27 |
| HK1119571A1 (es) | 2009-03-13 |
| IL186072A0 (en) | 2008-08-07 |
| PT1881826E (pt) | 2010-08-05 |
| ES2347174T3 (es) | 2010-10-26 |
| UA94044C2 (ru) | 2011-04-11 |
| ITMI20050909A1 (it) | 2006-11-20 |
| KR20080018898A (ko) | 2008-02-28 |
| EP1881826A1 (en) | 2008-01-30 |
| CA2604562A1 (en) | 2006-11-23 |
| SI1881826T1 (sl) | 2010-10-29 |
| CA2604562C (en) | 2013-09-17 |
| EA200702534A1 (ru) | 2008-04-28 |
| CN101166528B (zh) | 2011-06-15 |
| BRPI0609718A2 (pt) | 2011-10-18 |
| MX2007013491A (es) | 2008-01-24 |
| AU2006246688B2 (en) | 2011-09-22 |
| JP5086991B2 (ja) | 2012-11-28 |
| DK1881826T3 (da) | 2010-11-01 |
| ATE473739T1 (de) | 2010-07-15 |
| WO2006122680A1 (en) | 2006-11-23 |
| AU2006246688A1 (en) | 2006-11-23 |
| KR101312579B1 (ko) | 2013-09-30 |
| US8686021B2 (en) | 2014-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2009000780A1 (es) | Compuestos derivados de heterociclil-pirano-heterociclilo, heterociclil-oxepina-heterociclilo, benzopirano-heterociclilo y benzoxepina-heterociclilo sustituidos; composicion farmaceutica; procedimiento de preparacion de la composicion; kit farmaceutico; y su uso en el tratamiento del cancer, mediado por la inhibicion de pi3k. | |
| AR078588A1 (es) | Combinaciones de un inhibidor de pi3k y un inhibidor de mek | |
| EA201100698A1 (ru) | Производные тиенотриазолодиазепина, активные в отношении апо а1 | |
| AR072442A1 (es) | Metodo para la terapia del cancer, uso, kit | |
| NI201100100A (es) | Moduladores de aril metil benzoquinazolinona alostéricos positivos del receptor m1. | |
| EA201071298A1 (ru) | Соединение 3-аминокарбазола, фармацевтическая композиция, его содержащая, и способ их получения | |
| UY26977A1 (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos | |
| AR070047A1 (es) | Tratamientos terapeuticos contra el cancer. composicion que comprende un inhibidor de hedgehog. | |
| RU2013111077A (ru) | Дипептидное пролекарство, его применение и лекарственное средство | |
| DOP2009000201A (es) | Derivados de 3-amino-pirrolo[3,4-c]pirazol-5(1h, 4h, 6h)carbaldehido como inhibidores pkc | |
| UY30426A1 (es) | Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones. | |
| SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| CR20120062A (es) | Terapia combinada para el tratamiento de la diabetes | |
| EA201071039A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40 | |
| CO6341624A2 (es) | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoxi-etil)-4-trifluorometoxi-1h-indol-3-il]-metanona como un inhibidor de la triptasa de mastocitos | |
| DOP2005000039A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
| EA200870302A1 (ru) | 1,3-диоксанкарбоновые кислоты | |
| RU2008127882A (ru) | Лечение пищевода барретта | |
| CL2022001337A1 (es) | Derivados de piridopirimidinona como antagonistas de ahr | |
| AR087803A1 (es) | N-hidroxi-4-{2-[3-n,n-dimetilaminometil)benzofuran-2-ilcarbonilamino]etoxi}benzamida y esquema para administrarla | |
| AR054126A1 (es) | Utilizacion de un benzoilderivado del 3-aminocarbazol para la produccion de un farmaco para el tratamiento de un desorden asociado a la produccion de prostaglandina e2 (pge2) | |
| CL2024000738A1 (es) | Profármaco de derivados de pirrolidona como activador de glucocinasa | |
| MY156278A (en) | Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones | |
| AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina | |
| AR083393A1 (es) | Composicion farmaceutica liquida para el tratamiento y prevencion del dolor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed, e.g., due to non-payment of fee |